Mauro Ferrari, Director at ARROWHEAD PHARMACEUTICALS, INC. (ARWR), sold 7,530 shares at $70.00 ($527K) on 2025-12-26, disclosed to the SEC on 2025-12-30.
Scheduled sale ($527k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ARWR | SELL | 2021-12-29 | $454K | — | Filing → |
| ARWR | SELL | 2020-10-13 | $480K | — | Filing → |
| ARWR | SELL | 2019-06-28 | $980K | — | Filing → |